This study reviewed evidence suggesting that certain types of wounds might stimulate localized hairgrowth in humans, noting anecdotal reports and mixed efficacy of treatments like microneedling and lasers for androgenetic alopecia, but emphasized that further research is needed.
January 2018 in “Clinical approaches and procedures in cosmetic dermatology”
This review discusses clinical studies on low-level laser therapy for various types of hair loss and suggests it may be promising for those unresponsive to conventional treatments, but reports no new clinical results.
2 citations
,
January 2014 in “Journal of clinical and diagnostic research”
This review discusses various hair loss treatments, such as stem cell therapy, laser therapies, and mesotherapy, emphasizing their potential and limitations while highlighting the need for further research to address genetic factors in hair loss.
This article suggests that eyelash prostheses may exacerbate isotretinoin-induced blepharitis, highlighting the need for caution among young women using both products.
A 78-year-old man regrew hair after suffering burns, suggesting that injury-induced healing processes might trigger hairgrowth. Microneedling and other treatments like minoxidil and finasteride are discussed as potential methods to stimulate similar regrowth.
A 21-year-old started taking 1mg Finasteride daily for hair loss and considered adding Minoxidil for temple regrowth, questioning if stopping Minoxidil would cause hair loss despite continued Finasteride use. Responses suggest Minoxidil-inducedhair requires ongoing use to maintain, while Finasteride alone may not sustain Minoxidil gains, with some recommending microneedling or topical applications to enhance results.
SCUBE3 and GT20029 are potential treatments for hair loss, with SCUBE3 stimulating hairgrowth and GT20029 protecting against DHT. A combined approach using SCUBE3, finasteride or dutasteride, and later GT20029 could provide a comprehensive treatment for androgenetic alopecia.
PP405 may induce new hairgrowth but cannot revive completely dead follicles, and its effectiveness on hairlines is uncertain. It is expected to be available by mid-2028, but users are advised to manage expectations and consider using other treatments like minoxidil and finasteride.
Oleic acid, microneedling, and emu oil are discussed as potential hairgrowth treatments, with some users expressing skepticism about their effectiveness. Minoxidil and finasteride are recommended as current reliable treatments until more proven solutions are available.